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Abstract: PAS kinase is an evolutionarily conserved nutrient responsive protein kinase 
that regulates glucose homeostasis. Mammalian PAS kinase is activated by glucose in 
pancreatic beta cells, and knockout mice are protected from obesity, liver triglyceride 
accumulation, and insulin resistance when fed a high-fat diet. Yeast PAS kinase is 
regulated by both carbon source and cell integrity stress and stimulates the partitioning of 
glucose toward structural carbohydrate biosynthesis. In our current model for PAS kinase 
regulation, a small molecule metabolite binds the sensory PAS domain and activates the 
enzyme. Although bona fide PAS kinase substrates are scarce, in vitro substrate searches 
provide putative targets for exploration. 
Keywords: PAS kinase; PASKIN; glucose sensor; protein phosphorylation; PAS domain; 
metabolic syndrome 
 
1. Introduction 
1.1. Times of Plenty and Times of Scarcity 
Glucose is an important source of energy and metabolic fuel in both prokaryotes and eukaryotes. 
When glucose enters the cell, it can be used in a variety of different processes. For example, the central 
metabolic pathways conserved throughout all domains of life, namely glycolysis, the citric acid cycle 
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(TCA), and the pentose phosphate pathway, center around glucose consumption (catabolism) for the 
production of usable energy (ATP) and reducing equivalents (NAD(P)H). Glucose is also used in 
anabolic reactions such as the essential modification of proteins and the production of lipids and 
glycans for cellular proliferation. In addition to catabolic and anabolic reactions, glucose may be 
stored in carbohydrate form as glycogen or be converted to lipid for storage. Each of these processes 
must be regulated appropriately and dynamically to ensure maximum growth and survival of an 
organism through times of plenty and times of scarcity. This regulation often involves nutrient 
responsive protein kinases, which sense the cellular levels of metabolic intermediates and regulate 
metabolic pathways through protein phosphorylation. 
Although the presence of glucose in the environment signals nutrient richness to most organisms 
and cell types, their responses to glucose can be dramatically different. For example, in most 
eukaryotic organisms, high glucose levels stimulate glucose oxidation along with storage in the form 
of glycogen or fat, using times of plenty to yield high levels of ATP as well as to store for “lean 
times”. In contrast, when glucose levels are high the single celled fungi Saccharomyces cerevisiae 
primarily ferments glucose and leaves glucose storage for leaner times [1]. Although far less energy 
(ATP) is produced from fermentative metabolism, the high flux through glycolysis may provide 
metabolic building blocks for rapid growth, allowing the yeast to outcompete other organisms through 
glucose depletion. Such fermentative growth is seen in many highly proliferative cancer cells and is 
known as the Warburg effect [2]. 
The differential response to glucose by different cell types requires glucose sensing mechanisms 
coupled with diverse modes of metabolic regulation. For example, the 5′-AMP Activated Protein 
Kinase (AMPK) responds to low glucose levels (via a high AMP: ATP ratio) and down-regulates ATP 
utilization pathways while simultaneously up-regulating ATP production pathways (for recent reviews 
see [3,4]). The mammalian Target of Rapamycin (mTOR) protein responds to a variety of inputs to  
up-regulate protein synthesis and cell growth and proliferation when nutrients abound [5,6]. This 
review focuses on PAS kinase, a nutrient sensing protein kinase that is involved in glucose 
homeostasis in yeast [7-10] and mammals [11-16]. 
1.2. PAS Kinase Structure 
PAS kinase is broadly evolutionarily conserved amongst eukaryotes, having homologs in yeast, 
drosophila, mice and man, but is not found in C. elegans. Its sequence contains a C-terminal   
serine-threonine kinase domain and an N-terminal Per-ARNT-Sim (PAS) domain. By primary amino 
acid sequence, the serine-threonine kinase domain lies near the CAMK branch on the human kinome 
dendrogram [17]. The N-terminal PAS domain belongs to a large superfamily of PAS domains, 
comprising over 21,000 PFAM entries from all kingdoms of life [18,19]. PAS domains are sensory 
domains that frequently regulate an attached functional domain in cis, often by serving as a protein 
interaction surface. PAS domains are found attached to a variety of functional domains, including 
transcriptional activators, guanylate cyclases, phosphodiesterases, ion channels and kinases. Some 
PAS domains bind ligands within their cores allowing them to sense a variety of transient cellular and 
environmental conditions. PAS domains can either bind ligands reversibly like the citrate sensor CitA [20], 
or constitutively like the covalent binding of 4-hydroxycinnamic acid by the blue light sensing Sensors 2010, 10                              
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photoactive yellow protein [21,22] or the non-covalent heme-binding oxygen-sensing protein FixL [23]. 
PAS domains display low sequence conservation and high functional diversity, yet they contain a 
structurally conserved core of a five-stranded anti-parallel beta sheet surrounded by several alpha 
helices [19]. The conservation of general structure combined with the malleability of function make 
PAS domains good targets for structure-based design of artificial sensors where sensory PAS domains 
are covalently linked to effector domains of choice [24-26]. For example, Möglich et al. recently 
replaced the oxygen-sensing PAS domain of Bradyrhizobium japonicum FixL with the LOV 
photosensory PAS domain of Bacillus subtilis, resulting in a chimeric kinase that was regulated by 
blue light instead of oxygen  [24]. In addition, a plant derived blue-light sensing PAS domain has been 
fused to dihydrofolate reductase (DHFR) from E. coli, a protein that is not normally regulated by PAS 
domains. Remarkably, this fusion protein exhibited DHFR activity that was modestly regulated by 
blue light even without optimization of the construct [25]. 
A high resolution NMR structure of the human PAS kinase (hPASK) PAS domain was solved in the 
lab of Dr. Kevin Gardner [27] and it was found to be similar to other PAS domains including the  
well-characterized FixL heme-based oxygen sensor of Rhizobia [27]. The hPASK PAS domain adopts 
the typical α/β PAS domain fold with several α helices (Cα, Dα, Eα and Fα) surrounded by   
a 5-stranded (Aβ, Bβ, Gβ, Hβ, and Iβ) antiparallel beta sheet. In addition, the PAS domain contains an 
unusually long and dynamic loop segment (Fα/FG loop). The structure of this region is unlike any 
other PAS domain for which a three-dimensional structure is available [27-29]. Interestingly, 
Gardner’s group demonstrated that the PAS domain binds the kinase domain, even when supplied  
in trans, primarily using residues within the FG loop [27]. The PAS domain had been previously 
shown to inhibit the kinase domain when added in trans, and the combined data suggested an 
inhibitory direct protein-protein interaction [15]. 
In addition to solving the apo PAS domain structure, the Gardner lab also identified specific PAS 
domain ligands from a small molecule library and determined the region of the protein involved in 
ligand binding [27]. The PAS domain from PAS kinase exhibited binding selectivity, even 
discriminating amongst structurally similar ligands [27]. Although the small molecule ligands 
identified are nonphysiological, these ligands were bound in a similar manner to the FixL and Phy3 
ligands. Interestingly, ligand binding induces changes in the dynamics of the adjacent PAS domain FG 
loop and the surrounding region. In the FixL/heme complex, conformational changes in the FG loop, 
brought about by oxygen binding to the distal face of the heme, are thought to modulate the activity of 
the kinase domain [30,31]. A similar mechanism of kinase activity modulation is likely for PAS kinase 
as well since the FG loop was identified as the primary surface for kinase domain interaction. The 
structural details of how FG loop conformation regulates PAS kinase activity, however, might be quite 
distinct from FixL and other sensory histidine kinases, wherein effector domains are connected to the 
C-terminus of the PAS domain by short α-helical and coiled-coil linkers that are believed to transmit 
the PAS domain signal [19]. In contrast, PAS kinase has a long linker (at least 400 amino acids) and 
appears to display a direct interaction between the PAS domain and the effector (kinase) domain. 
Additional evidence for PAS domain regulation of kinase activity arises from the finding that PAS 
domain mutants, which were designed to mimic the ligand bound state (I203F and C228F), lead to 
increased PASK activity in the context of the full length protein or failed to inhibit kinase activity 
when supplied in trans [15,27]. Sensors 2010, 10                              
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1.3. A Model for PAS Kinase Activation and Function 
In the current model of PAS kinase activation and function, the PAS domain binds to and inhibits 
the kinase domain (Figure 1). This binding and inhibition may be disrupted by the association of a 
small molecule metabolite or protein with the PAS domain. There is no evidence for a constitutively 
associated ligand from the biochemical and structural work and ligand binding might be transient as 
attempts at biochemical purification of a PAS domain ligand have failed (our unpublished data). Stable 
activation may, therefore, also entail subsequent auto- or transphosphorylation, as typical of many 
protein kinases. Human PAS kinase has been shown to autophosphorylate at multiple sites in vitro 
[15], and another phosphosite (Ser116) was detected in a large scale search for nuclear 
phosphoproteins in HeLa cells [32]. The functional importance of these phosphosites in the regulation 
of endogenous PAS kinase, however, remains unclear. 
Figure 1. A model for PAS kinase regulation and function. The PAS domain binds to and 
inhibits the kinase domain. A metabolite (green star) or protein activates PAS kinase by 
binding to the PAS domain and relieving PAS domain inhibition. This transient activation 
may be subsequently stabilized through auto- or transphosphorylation. PAS kinase is then 
competent to phosphorylate substrates involved in glucose partitioning and translation (in 
S. cerevisiae) to elicit the appropriate physiological response. 
 
1.4. Expression and Subcellular Localization 
The regions of PAS kinase with the greatest interspecies conservation lie within the PAS and kinase 
domains (Figure 2). For example the S. cerevisiae Psk1 and Psk2 kinase domains have 61% and 62% 
similarity to the human PASK kinase domain, respectively. The region between the PAS and kinase 
domains may be important for substrate recognition since it was shown to be critical for interaction 
between PAS kinase and one of its substrates [16]. PAS kinase is predominantly found in the 
cytoplasm of both HeLa Cells [15,35] and yeast cells [36], but was detected by mass spectrometry in 
HeLa cell nuclear extracts [32,35]. Studies in mice suggest that PAS kinase is expressed ubiquitously 
at a low level in tissues other than the testes, where the mRNA and protein level is roughly 100-fold 
higher than that of most other tissues [37,38]. 
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Figure 2. Alignment of the PAS and kinase domains from selected PAS kinase orthologs. 
(A) Schematic of PAS kinase homologs. Regions of similarity are boxed in grey, with  
non-homologous regions indicated by gaps between the grey boxes. Alignment of the PAS 
(B) and kinase (C) domains from selected PAS kinase orthologs. Secondary structure 
elements (α-helical and β-sheet) were derived from the published NMR structure of the 
PAS domain [27] as well as amino acid alignment of the kinase domain with the published 
structure of microtubule-associate protein/microtubule affinity regulating kinase 2 
(MARK2) [33], and are shown above the amino acids in green and purple respectively. 
Amino acid sequences were aligned using the Clustal W program [34]. The degree of 
amino acid conservation is indicated both by color and “*” (identical residues in all 
sequences), “:” (highly conserved amino acids), and “.” (weakly conserved amino acids). 
Red indicates a small hydrophobic or aromatic amino acid (-Y), blue indicates acidic, 
magenta is basic, and green is hydroxyl plus amine plus basic (-Q), all other amino acids 
are grey. 
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2. PAS Kinase Glucose Sensing 
2.1. Mammalian PAS Kinase 
 
PAS kinase is rapidly (within 1 hour) post-translationally activated by high glucose in cultured 
mouse pancreatic beta-cells [11,12]. This activation is followed by an increase in both PAS kinase 
mRNA and protein (24 hours) and is independent of insulin concentration. The primary function of 
beta-cells is to synthesize and secrete insulin in response to high glucose levels. Through binding to its 
receptor on target cells, insulin stimulates the uptake of serum glucose by the muscle and adipose 
tissue and inhibits hepatic glucose production. In addition to causing insulin secretion, high glucose 
also stimulates transcription of the preproinsulin gene. PAS kinase overexpression mimics this effect 
of high glucose and causes induction of the preproinsulin promoter even in low glucose, while   
RNAi-mediated depletion of PAS kinase suppresses glucose-induced preproinsulin up-regulation [11].  
Fatty acids impair the glucose responsiveness of insulin gene transcription. This and related 
phenomena, known as glucolipotoxicity, might underlie the pancreatic beta-cell failure observed in 
Type 2 Diabetes [39]. Similarly, the glucose-induced increase in PAS kinase gene expression was 
recently shown to be inhibited by the fatty acid palmitate [12]. Interestingly, PAS kinase 
overexpression mitigates the effects of palmitate on glucose-induced expression of preproinsulin and 
pancreatic duodenal homeobox-1 (PDX-1), a transcription factor required for preproinsulin expression 
and pancreatic beta cell function [12]. These observations raise the possibility that PAS kinase is a key 
mediator of the effects of glucose and fatty acids on insulin expression in pancreatic beta-cells. While 
the physiological significance is unclear, purified PAS kinase efficiently phosphorylates purified   
PDX-1 on Thr152 [40]. 
In addition to a role in beta-cell insulin gene expression, PAS kinase appears to function in 
peripheral tissues in regulating glucose homeostasis in mice. In light of the evolutionary conservation 
of PAS kinase, it was surprising that PASK knockout mice have no overt phenotype when fed a 
normal chow diet [13,41]. However, when these mice were challenged with a high-fat diet, they were 
protected from an array of phenotypes similar to the metabolic syndrome, including obesity, liver 
triglyceride accumulation, glucose intolerance and insulin resistance [13]. The most striking 
phenotype, protection from liver triglyceride accumulation, was accompanied by a significant decrease 
in the levels of mRNAs encoding SCD1, which catalyzes a rate limiting step in triglyceride 
biosynthesis, CD36, a putative fatty acid transporter, and PPARγ, which controls expression of the 
CD36 gene and other genes involved in fat accumulation [13]. Although the molecular mechanisms of 
these phenotypes are unknown, a higher metabolic rate may be involved since the PAS kinase-
deficient mice display increased O2 consumption and CO2 release [13]. This higher metabolic rate is 
not due to an increase in mitochondria mass or number, or activation of the AMPK pathway in muscle 
or liver [13]. 
 
2.2 Yeast PAS Kinase 
 
Yeast PAS kinase also appears to be regulated in response to high glucose, although in the opposite 
manner. The genome of the yeast S. cerevisiae encodes two homologs of PAS kinase, Psk1 and Psk2 Sensors 2010, 10                              
 
 
5674
(see Figure 2). Although highly similar in the PAS and kinase domains, Psk1 has an extra ~250 amino 
acids distributed throughout the N-terminus. The yeast PAS kinase homologs are posttranslationally 
activated by two stimuli, growth on nonfermentative carbon source (carbon sources other than 
glucose) and growth under conditions of cell integrity stress [7]. When glucose is available, yeast 
preferentially ferment the glucose and repress the expression of over 100 genes involved in respiratory 
metabolism in a process known as glucose repression [1,42]. This process is under the control of the 
yeast AMPK homolog, Snf1, the master regulator of glucose repression. Snf1 is necessary and 
sufficient for PAS kinase activation by nonfermentative carbon sources; that is, PAS kinase is 
constitutively activated when Snf1 is constitutively activated (via a reg1 mutation), while it is not 
activated in the reg1 snf1 double mutant [7]. The activation of PAS kinase by nonfermentative growth 
conditions may be mechanistically related to the activation of PAS kinase by high glucose in 
mammalian beta-cells since both conditions activate respiratory metabolism. 
Interestingly, only Psk1 is activated by nonfermentative carbon source due to down regulation of 
Psk2 transcription under these conditions, while both Psk1 and Psk2 are capable of responding to cell 
integrity stress [7]. The differential regulation of the two PAS kinase homologs argues for specialized 
functions, as does the evolutionary selection for both genes [8]. The presence of two PAS kinase 
homologs is most likely the result of a whole genome duplication that occurred in an S. cerevisiae 
ancestor [43]. Most of the genome duplication was subsequently deselected and lost by mutation, 
however, some of the redundant proteins evolved specialized functions that were selected and 
maintained [44-46]. Although both Psk1 and Psk2 phosphorylate Ugp1, the one definitively validated 
yeast substrate, specialized functions may be revealed as more substrates are identified. 
3. PAS Kinase Regulation of Glucose Partitioning 
 
3.1. Glucose Partitioning and the Regulation of Glycogen Biosynthesis 
 
A biochemical screen of fractionated yeast proteins yielded four putative PAS kinase substrates: 
UDP-glucose pyrophosphorylase (Ugp1), eukaryotic translation initiation factor 1A (eIF1A or Tif11), 
cap-associated factor (Caf20), and Sro9, a ribosome-associated protein [9]. A summary of putative 
PAS kinase substrates is listed in Table 1. Of these four targets, only Ugp1 has been shown to be 
physiologically relevant as expression of the unphosphorylatable mutant (Ugp1-S11A) causes a 
phenotype identical to the psk1 psk2 double PAS kinase mutant, namely sensitivity to cell wall 
perturbing agents and hyperaccumulation of glycogen [10]. Ugp1 is an essential protein that catalyzes 
the conversion of glucose-1-phosphate and UTP to UDP-glucose. Its product, UDP-glucose, is utilized 
as a glucose donor in a variety of cellular processes ranging from biosynthesis of glycogen and cell 
wall glycans to the glycosylation of proteins [47]. Surprisingly, PAS kinase-dependent 
phosphorylation of Ugp1 does not alter its enzymatic activity. Instead, phosphorylation alters the final 
destination of its product, favoring cell wall glucan biosynthesis at the expense of glycogen 
biosynthesis [10]. This altered glucose partitioning in response to phosphorylation most likely occurs 
through relocalization of cytoplasmic Upg1 to the cell periphery where it may interact with cell wall 
biosynthetic enzymes [10]. Thus, the observed activation of PAS kinase by growth conditions that Sensors 2010, 10                              
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elicit cell integrity stress (see above) would result in increased formation of cell wall glucans 
necessary for repair.  
Table 1. In vitro and in vivo substrates of PAS kinase. 
Putative substrate  Site(s)  Species  Evidence  Reference 
Glucose-partitioning 
Pancreatic duodenal homeobox 1 (PDX1)  Thr152  H. sapiens  in vitro phosphorylation  [40] 
Glycogen synthase (Gsy)  Ser640  H. sapiens  in vitro phosphorylation; 
copurification 
[16] 
 Ser654  S. cerevisiae  In vitro phosphorylation;   [9] 
UDP-glucose pyrophosphorylase (Ugp1)  Ser11  S. cerevisiae  in vitro & in vivo 
phosphorylation 
[7,9,10] 
Translation-related        
Translation initiation factor eIF1A  Ser125  S. cerevisiae  in vitro phosphorylation  [9] 
 Thr432  H. sapiens  in vitro phosphorylation; 
coimmunoprecipitation; 
colocalization; 
yeast 2-hybrid 
[35] 
Caf20 Ser58 
Ser59  
c-term* 
S. cerevisiae  in vitro phosphorylation  [9] 
Sro9 Thr101 
Thr103 
S. cerevisiae  in vitro phosphorylation  [9] 
Alanyl tRNA Synthetase (Alars)  Ser732  H. sapiens  in vitro phosphorylation  [48] 
Basic Transcription Factor 3(BTF3)  Thr38  H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S3A (RPS3A)  Ser154  H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S2     H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S6     H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S8     H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S10     H. sapiens  in vitro phosphorylation  [48] 
Ribosomal Protein S14     H. sapiens  in vitro phosphorylation  [48] 
*multiple phosphorylation events on the C-terminal 68 amino acids were reported. 
 
Glycogen is the predominant storage carbohydrate and, thus, the proper regulation of glycogen 
metabolism is essential to energy homeostasis in both yeast and mammals. Dysregulation of glycogen 
metabolism has been shown to play a role in the development of a variety of diseases, including  
type 2 diabetes [49-51]. While the Ugp1 Ser11 phosphorylation site is not found in mammals, the role 
of PAS kinase in the regulation of glycogen synthesis and glucose partitioning in general appears to be 
conserved. The enzyme glycogen synthase is the enzyme responsible for glycogen biosynthesis and is 
the key regulatory point for glycogen synthesis [52,53]. Glycogen synthase is regulated by multi-site 
phosphorylation in both yeast and mammals, with a total of nine phosphorylation sites identified. 
Glycogen synthase kinase-3 (GSK-3) has been shown to phosphorylate some of these sites, however, 
other glycogen synthase kinases must exist since glycogen synthase is phosphorylated at critical sites Sensors 2010, 10                              
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(Ser640 and Ser644) even when GSK-3 activity is blocked [54]. PAS kinase efficiently phosphorylates 
purified mammalian glycogen synthase at Ser640, the phosphosite with the most dramatic effects on 
activity and a PAS kinase/glycogen synthase interaction can be detected by copurification [54]. 
Interestingly, this phosphorylation requires a region upstream of the kinase catalytic domain (amino 
acids 444-955), as does copurification of PAS kinase with glycogen synthase [16]. This region appears 
to be responsible for the kinase/substrate interaction, which is disrupted by excess glycogen [16]. 
Yeast PAS kinase also phosphorylates glycogen synthase (Gsy2) in vitro and psk1 psk2 mutant yeast 
display elevated glycogen synthase activity [9].  
 
3.2. A Role for PAS Kinase in Translation 
 
The three remaining putative yeast PAS kinase substrates identified in the biochemical screen were 
proteins involved in translation: eukaryotic translation initiation factor 1A (eIF1A or Tif11),   
cap-association factor (Caf20), and Sro9 [9]. The eIF1A protein generates the 40S ribosomal 
preinitiation complex by catalyzing the transfer of Met-tRNA [55,56]. In addition, it has been shown to 
be involved in a wide variety of processes including RNA synthesis, apoptosis, cytoskeletal 
organization, activation of the heat shock transcription factor, and proteasomal degradation of 
damaged proteins [57]. Human eIF1A also appears to be a PAS kinase substrate since it is 
phosphorylated in vitro (at Thr432) and interacts with PAS kinase in vivo as shown by both yeast  
two-hybrid and GST pull-down assays [35]. In addition, eIF1A colocalizes with PAS kinase at the 
mid-tail region of mature sperm, which contains cytoskeletal components as well as mitochondria and 
glycolytic enzymes. Interestingly, in contrast to glycogen synthase, eIF1A copurification occurred 
with either the PAS domain or the kinase domain, but not the intervening region of PASK [35].  
The remaining two in vitro yeast substrates, Caf20 and Sro9, are also involved in translation. Caf20 
is a phosphoprotein that negatively regulates cap-dependent translation by binding eIF4E and 
inhibiting formation of the eIF4E/eIF4G complex [58,59]. Subsequent experiments revealed that the 
Caf20 protein is not phosphorylated in vitro in the absence of its partner eukaryotic initiation factor 4E 
(eIF4E). Sro9 is a cytoplasmic protein of unknown function that associates with translating ribosomes 
[60]. It regulates Hap1 as a component of the HMC complex [61] and appears to be involved in actin 
filament organization [62]. 
An analogous in vitro screen using human PAS kinase and fractionated HeLa cell extracts also 
identified putative PAS kinase substrates that are involved in translation [48]. Human PAS kinase was 
shown to phosphorylate ribosomal proteins S2, S6, S8, S10, S14, S3A (RPS3A), basic transcription 
factor 3 (BTF3), and alanyl-tRNA synthetase (AlaRS) (see Table 1) [48]. Like the yeast Caf20, BTF3 
contains a sequence that binds to eIF4E [63]. The eIF4E binding proteins generally regulate translation 
in response to cellular conditions and some tether eIF4E to specific mRNAs (for a recent review see [64]). 
The ribosomal protein S3A is also involved in translational initiation and binds the small ribosomal 
subunit and iMET [65,66]. In addition, AlaRS may play a more direct role in translational regulation 
since various tRNAs have also been shown to bind to specific mRNAs and inhibit their translation 
[67]. PAS kinase phosphorylates AlaRS on Ser732, which lies between the tRNA editing and 
oligomerization domains [48]. The physiological consequences of these translation-related 
phosphorylation events in both yeast and mammals are unknown. In vivo phosphorylation by PAS Sensors 2010, 10                              
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kinase may not regulate translation initiation or elongation rates. Probst et al. recently pointed out [48] 
that other reported ribosomal phosphorylation events do not change these reaction rates but instead 
alter the specificity of the ribosome for particular mRNAs [68].  
Although further studies are necessary to elucidate the role of PAS kinase in translation, PAS 
kinase overexpression in yeast rescues the temperature sensitivity and protein synthesis defects of a 
strain lacking Stm1 (Tif3), the yeast eIF4B translation initiation factor [9]. Additionally, a high copy 
suppressor screen for genes that suppress the psk1 psk2 double mutant phenotype when overexpressed 
yielded genes encoding proteins involved in translation initiation [9]. Many of the proteins discussed 
above also play a role in mRNA stability, which is closely linked to ribosomal function. Interestingly, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was also identified in the in vitro screen for 
PAS kinase substrates and has also been shown to play a role in mRNA stability by associating with 
polysomes and cis acting elements [69]. The GAPDH phosphorylation site (Thr237) is conserved 
across all species and positioned at the homotetramer interface. 
4. Conclusions  
The presence of both a sensory PAS domain and a canonical serine/threonine kinase domain posit a 
role for PAS kinase in metabolic regulation (see figure 1 for a summary of PAS kinase regulation and 
function). The regulation of PAS kinase in response to cellular status has been documented in both 
mammalian beta-cells and yeast, with the unifying theme of activation under conditions that induce 
respiration (high glucose in pancreatic beta cells and nonfermentative carbon sources in yeast). 
However, the precise role of PAS kinase as a metabolic sensor awaits the identification of a biological 
ligand (either a small molecule or protein) that binds to the PAS domain and activates the enzyme. 
This identification is a formidable task since the PAS domain/ligand interaction is most likely 
transient, as no protein or small molecule ligands have been discovered despite repeated attempts at 
biochemical purification (unpublished). Additionally, PAS kinase activation may require auto- or 
transphosphorylation and key PAS kinase residues have been shown to be phosphorylated, however 
the in vivo relevance of phosphorylation remains unknown [15,32]. The presence of a regulating ligand 
does not preclude phosphorylation as a mechanism to stabilize the activated state. 
PAS kinase inhibition may prove to be a valid therapeutic target in the defense against the 
metabolic syndrome since PAS kinase-deficient mice are protected against weight gain, liver 
triglyceride accumulation and insulin resistance when fed a high-fat diet [13]. Intriguingly, these mice 
display no phenotype when fed a normal chow diet. The molecular mechanisms behind these 
phenotypes, specifically the identification of PAS kinase substrates and interacting partners, will 
provide valuable insight into PAS kinase function. 
PAS kinase regulates glucose homeostasis in yeast primarily through the phosphorylation of   
Ugp1 [9,10]. Ugp1 is the cellular source of UDP-glucose, an essential carrier of glucose. 
Phosphorylation of Ugp1 directs the flow of glucose towards the biosynthesis of structural 
carbohydrates at the expense of glycogen [7,8,10]. Although the phosphorylation site (Ser11) is not 
conserved in mammalian cells, both yeast and mammalian glycogen synthase proteins are putative 
PAS kinase substrates [9,16]. Many proteins and pathways are well conserved from yeast to man. 
Thus, the pathways regulated by PAS kinase in yeast may be similar to the mammalian pathways even Sensors 2010, 10                              
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if the actual phosphorylated substrates may vary. Although bona fide PAS kinase substrates are scarce, 
the recent identification of PAS kinase-activating stimuli [8,11] and in vitro yeast and mammalian 
PAS kinase substrates [9,48] should greatly aid in elucidating its regulation and function. 
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